With reference to the query raised by BSE through email dated February 4, 2025 regarding ‘Date of Share Subscription and Shareholders’ Agreement not given.’ with respect to announcement bearing reference no. ADL/SE/2024-25/127 dated February 3, 2025, Aarti Drugs has submitted the revised disclosure in line with query raised by BSE. The Company has on Monday, February 3, 2025, entered into a ‘Share Subscription and Shareholders’ Agreement’ with ‘Prozeal Green Power Private Limited’ and ‘Pro-Zeal Green Power Nine Private Limited’. This transaction entails acquisition of 26.25% Equity Shares/ Voting Rights and Compulsory Convertible Debentures by the Company in ‘Pro-Zeal Green Power Nine Private Limited’- a Special Purpose Vehicle (SPV) formed for developing, constructing, operating and maintaining a 24.40 MWp (19.36 MW) solar power plant exclusively to cater the Company’s power requirement partly. This is in line with the Company’s commitment towards procuring power through renewable resources. The detailed disclosures as required under SEBI Circular no. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, are enclosed as Annexure-A.
The above information is a part of company’s filings submitted to BSE.